Worldwide practice in gastric cancer surgery

World Journal of Gastroenterology

Volumn 22, Issue 15, 2016, Pages 4041-4048

  Brenkman, Hylke J F ^a   Haverkamp, Leonie ^a   Ruurda, Jelle P ^a   Van Hillegersberg, Richard ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Gastrectomy; Gastric cancer; Laparoscopy; Minimally invasive surgery; Neoplasm

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; CLINICAL EVALUATION; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; EARLY CANCER; GREATER OMENTUM; HEALTH CARE SURVEY; HUMAN; LYMPH NODE DISSECTION; MINIMALLY INVASIVE PROCEDURE; STOMACH CANCER; TOTAL STOMACH RESECTION; ADJUVANT CHEMOTHERAPY; CANCER STAGING; GASTRECTOMY; HIGH VOLUME HOSPITAL; LOW VOLUME HOSPITAL; MINIMALLY INVASIVE SURGERY; NEOADJUVANT THERAPY; PATHOLOGY; STOMACH NEOPLASMS; TRENDS;

CHEMOTHERAPY, ADJUVANT; CROSS-SECTIONAL STUDIES; GASTRECTOMY; HEALTH CARE SURVEYS; HOSPITALS, HIGH-VOLUME; HOSPITALS, LOW-VOLUME; HUMANS; LYMPH NODE EXCISION; MINIMALLY INVASIVE SURGICAL PROCEDURES; NEOADJUVANT THERAPY; NEOPLASM STAGING; PRACTICE PATTERNS, PHYSICIANS'; STOMACH NEOPLASMS;

EID: 84963541104     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i15.4041     Document Type: Article

References (44)

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-E386 [PMID: 25220842 DOI: 10.1002/ijc.29210]
2. Japanese Gastric Cancer Association. Japanese Classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011; 14: 101-112 [PMID: 21573743 DOI: 10.1007/s10120-011-0041-5]
3. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011; 14: 113-123 [PMID: 21573742 DOI: 10.1007/s10120-011-0042-4]
4. Callahan MA, Christos PJ, Gold HT, Mushlin AI, Daly JM. Influence of surgical subspecialty training on in-hospital mortality for gastrectomy and colectomy patients. Ann Surg 2003; 238: 629-636; discussion 636-639 [PMID: 14530734 DOI: 10.1097/01. sla.0000089855.96280.4a]
5. Bachmann MO, Alderson D, Edwards D, Wotton S, Bedford C, Peters TJ, Harvey IM. Cohort study in South and West England of the Influence of specialization on the management and outcome of patients with oesophageal and gastric cancers. Br J Surg 2002; 89: 914-922 [PMID: 12081743 DOI: 10.1046/j.1365-2168.2002.02135. x]
6. Birkmeyer JD, Siewers AE, Finlayson E V, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346: 1128-1137 [PMID: 11948273 DOI: 10.1056/NEJMsa012337]
7. Hannan EL, Radzyner M, Rubin D, Dougherty J, Brennan MF. The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery 2002; 131: 6-15 [PMID: 11812957 DOI: 10.1067/msy.2002.120238]
8. Jensen LS, Nielsen H, Mortensen PB, Pilegaard HK, Johnsen SP. Enforcing centralization for gastric cancer in Denmark. Eur J Surg Oncol 2010; 36 Suppl 1: S50-S54 [PMID: 20598495 DOI: 10.1016/j.ejso.2010.06.025]
9. Dikken JL, van Sandick JW, Allum WH, Johansson J, Jensen LS, Putter H, Coupland VH, Wouters MW, Lemmens VE, van de Velde CJ, van der Geest LG, Larsson HJ, Cats A, Verheij M. Differences in outcomes of oesophageal and gastric cancer surgery across Europe. Br J Surg 2013; 100: 83-94 [PMID: 23180474 DOI: 10.1002/bjs.8966]
10. Kim W, Kim HH, Han SU, Kim MC, Hyung WJ, Ryu SW, Cho GS, Kim CY, Yang HK, Park do J, Song KY, Lee SI, Ryu SY, Lee JH, Lee HJ; Korean Laparo-endoscopic Gastrointestinal Surgery Study (KLASS) Group. Decreased Morbidity of Laparoscopic Distal Gastrectomy Compared With Open Distal Gastrectomy for Stage I Gastric Cancer: Short-term Outcomes From a Multicenter Randomized Controlled Trial (KLASS-01). Ann Surg 2016; 263: 28-35 [PMID: 26352529 DOI: 10.1097/SLA.0000000000001346]
11. Viñuela EF, Gonen M, Brennan MF, Coit DG, Strong VE. Laparoscopic versus open distal gastrectomy for gastric cancer: a meta-analysis of randomized controlled trials and high-quality nonrandomized studies. Ann Surg 2012; 255: 446-456 [PMID: 22330034 DOI: 10.1097/SLA.0b013e31824682f4]
12. Zeng YK, Yang ZL, Peng JS, Lin HS, Cai L. Laparoscopy-assisted versus open distal gastrectomy for early gastric cancer: evidence from randomized and nonrandomized clinical trials. Ann Surg 2012; 256: 39-52 [PMID: 22664559 DOI: 10.1097/SLA.0b013e3182583e2e]
13. Jiang L, Yang KH, Guan QL, Cao N, Chen Y, Zhao P, Chen YL, Yao L. Laparoscopy-assisted gastrectomy versus open gastrectomy for resectable gastric cancer: an update meta-analysis based on randomized controlled trials. Surg Endosc 2013; 27: 2466-2480 [PMID: 23361259 DOI: 10.1007/s00464-012-2758-6]
14. Haverkamp L, Weijs TJ, van der Sluis PC, van der Tweel I, Ruurda JP, van Hillegersberg R. Laparoscopic total gastrectomy versus open total gastrectomy for cancer: a systematic review and meta-analysis. Surg Endosc 2013; 27: 1509-1520 [PMID: 23263644 DOI: 10.1007/s00464-012-2661-1]
15. Wang W, Zhang X, Shen C, Zhi X, Wang B, Xu Z. Laparoscopic versus open total gastrectomy for gastric cancer: an updated meta-analysis. PLoS One 2014; 9: e88753 [PMID: 24558421 DOI: 10.1371/journal.pone.0088753]
16. Hur H, Lee HY, Lee HJ, Kim MC, Hyung WJ, Park YK, Kim W, Han SU. Efficacy of laparoscopic subtotal gastrectomy with D2 lymphadenectomy for locally advanced gastric cancer: the protocol of the KLASS-02 multicenter randomized controlled clinical trial. BMC Cancer 2015; 15: 355 [PMID: 25939684 DOI: 10.1186/s12885-015-1365-z]
17. Haverkamp L, Brenkman HJ, Seesing MF, Gisbertz SS, van Berge Henegouwen MI, Luyer MD, Nieuwenhuijzen GA, Wijnhoven BP, van Lanschot JJ, de Steur WO, Hartgrink HH, Stoot JH, Hulsewé KW, Spillenaar Bilgen EJ, Rütter JE, Kouwenhoven EA, van Det MJ, van der Peet DL, Daams F, Draaisma WA, Broeders IA, van Stel HF, Lacle MM, Ruurda JP, van Hillegersberg R. Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial). BMC Cancer 2015; 15: 556 [PMID: 26219670 DOI: 10.1186/s12885-015-1551-z]
18. Straatman J, van der Wielen N, Cuesta MA, Gisbertz SS, Hartemink KJ, Alonso Poza A, Weitz J, Mateo Vallejo F, Ahktar K, Diez Del Val I, Roig Garcia J, van der Peet DL. Surgical techniques, open versus minimally invasive gastrectomy after chemotherapy (STOMACH trial): study protocol for a randomized controlled trial. Trials 2015; 16: 123 [PMID: 25873249 DOI: 10.1186/s13063-015-0638-9]
19. Jeong O, Ryu S Y, Choi W Y, Piao Z, Park YK. Risk factors and learning curve associated with postoperative morbidity of laparoscopic total gastrectomy for gastric carcinoma. Ann Surg Oncol 2014; 21: 2994-3001 [PMID: 24687152 DOI: 10.1245/s10434-014-3666-x]
20. Jung do H, Son SY, Park YS, Shin DJ, Ahn HS, Ahn SH, Park do J, Kim HH. The learning curve associated with laparoscopic total gastrectomy. Gastric Cancer 2016; 19: 264-272 [PMID: 25481705 DOI: 10.1007/s10120-014-0447-y]
21. Zong L, Chen P, Chen Y, Shi G. Pouch Roux-en-Y vs No Pouch Roux-en-Y following total gastrectomy: a meta-analysis based on 12 studies. J Biomed Res 2011; 25: 90-99 [PMID: 23554676 DOI: 10.1016/S1674-8301(11)60011-0]
22. Kalmár K, Cseke L, Zámbó K, Horváth OP. Comparison of quality of life and nutritional parameters after total gastrectomy and a new type of pouch construction with simple Roux-en-Y reconstruction: preliminary results of a prospective, randomized, controlled study. Dig Dis Sci 2001; 46: 1791-1796 [PMID: 11508685 DOI: 10.1023/A:1010634427766]
23. Fein M, Fuchs KH, Thalheimer A, Freys SM, Heimbucher J, Thiede A. Long-term benefits of Roux-en-Y pouch reconstruction after total gastrectomy: a randomized trial. Ann Surg 2008; 247: 759-765 [PMID: 18438112 DOI: 10.1097/SLA.0b013e318167748c]
24. Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmülling C, Neugebauer E, Troidl H. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 1995; 82: 216-222 [PMID: 7749697 DOI: 10.1002/bjs.1800820229]
25. Kim T, Yu W, Chung H. Handsewn versus stapled gastroduo-denostomy in patients with gastric cancer: long-term follow-up of a randomized clinical trial. World J Surg 2011; 35: 1026-1029 [PMID: 21424150 DOI: 10.1007/s00268-011-1038-2]
26. Seufert RM, Schmidt-Matthiesen A, Beyer A. Total gastrectomy and oesophagojejunostomy-a prospective randomized trial of hand-sutured versus mechanically stapled anastomoses. Br J Surg 1990; 77: 50-52 [PMID: 2405935 DOI: 10.1002/bjs.1800770118]
27. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ, Welvaart K, Songun I, Meyer S, Plukker JT, Van Elk P, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999; 340: 908-914 [PMID: 10089184 DOI: 10.1056/NEJM199903253401202]
28. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999; 79: 1522-1530 [PMID: 10188901 DOI: 10.1038/sj.bjc.6690243]
29. Bonenkamp JJ, van de Velde CJ. Lymph node dissection in gastric cancer. Br J Surg 1995; 82: 867-869 [PMID: 7648094 DOI: 10.1002/bjs.1800820703]
30. Degiuli M, Sasako M, Ponti A, Vendrame A, Tomatis M, Mazza C, Borasi A, Capussotti L, Fronda G, Morino M; Italian Gastric Cancer Study Group. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg 2014; 101: 23-31 [PMID: 24375296 DOI: 10.1002/bjs.9345]
31. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010; 11: 439-449 [PMID: 20409751 DOI: 10.1016/S1470-2045(10)70070-X]
32. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M. Extended lymph node dissection for gastric cancer: who may beneft? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 2004; 22: 2069-2077 [PMID: 15082726 DOI: 10.1200/JCO.2004.08.026]
33. Wu CW, Hsiung CA, Lo SS, Hsieh MC, Chen JH, Li AF, Lui WY, Whang-Peng J. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 2006; 7: 309-315 [PMID: 16574546 DOI: 10.1016/S1470-2045(06)70623-4]
34. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K; Japan Clinical Oncology Group. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008; 359: 453-462 [PMID: 18669424 DOI: 10.1056/NEJMoa0707035]
35. Galizia G, Lieto E, De Vita F, Castellano P, Ferraraccio F, Zamboli A, Mabilia A, Auricchio A, De Sena G, De Stefano L, Cardella F, Barbarisi A, Orditura M. Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis. Surgery 2015; 157: 285-296 [PMID: 25532433 DOI: 10.1016/j.surg.2014.09.012]
36. Hasegawa S, Kunisaki C, Ono H, Oshima T, Fujii S, Taguri M, Morita S, Sato T, Yamada R, Yukawa N, Rino Y, Masuda M. Omentum-preserving gastrectomy for advanced gastric cancer: a propensity-matched retrospective cohort study. Gastric Cancer 2013; 16: 383-388 [PMID: 22983455 DOI: 10.1007/s10120-012-0198-6]
37. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ; MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11-20 [PMID: 16822992 DOI: 10.1056/NEJMoa055531]
38. Messager M, de Steur WO, van Sandick JW, Reynolds J, Pera M, Mariette C, Hardwick RH, Bastiaannet E, Boelens PG, van deVelde CJ, Allum WH; EURECCA Upper GI Group. Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre). Eur J Surg Oncol 2016; 42: 116-122 [PMID: 26461256 DOI: 10.1016/j.ejso.2015.09.017]
39. Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, Lee KW, Kim YH, Noh SI, Cho JY, Mok YJ, Kim YH, Ji J, Yeh TS, Button P, Sirzén F, Noh SH; CLASSIC trial investigators. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet 2012; 379: 315-321 [PMID: 22226517 DOI: 10.1016/S0140-6736(11)61873-4]
40. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K; ACTS-GC Group. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007; 357: 1810-1820 [PMID: 17978289 DOI: 10.1056/NEJMoa072252]
41. GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group, Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon JP, Rougier P, Sakamoto J, Sargent D, Sasako M, Van Cutsem E, Buyse M. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA 2010; 303: 1729-1737 [PMID: 20442389 DOI: 10.1001/jama.2010.534]
42. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725-730 [PMID: 11547741 DOI: 10.1056/NEJMoa010187]
43. Dikken JL, van Sandick JW, Maurits Swellengrebel HA, Lind PA, Putter H, Jansen EP, Boot H, van Grieken NC, van de Velde CJ, Verheij M, Cats A. Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS). BMC Cancer 2011; 11: 329 [PMID: 21810227 DOI: 10.1186/1471-2407-11-329]
44. Park SH, Sohn TS, Lee J, Lim do H, Hong ME, Kim KM, Sohn I, Jung SH, Choi MG, Lee JH, Bae JM, Kim S, Kim ST, Park JO, Park YS, Lim H Y, Kang WK. Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses. J Clin Oncol 2015; 33: 3130-3136 [PMID: 25559811 DOI: 10.1200/JCO.2014.58.3930]